Peripheral Interventions Market - By Product (Catheters, Sheath, Stents, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters), By Application (Peripheral Artery Disease, Venous Thromboembolism), By End-use, – Forecast, 2023-2032

Peripheral Interventions Market Size

Peripheral Interventions Market size reached USD 8.7 billion in 2022 and is set to expand significantly at more than 9% CAGR from 2023-2032, driven by the rising prevalence of peripheral artery diseases across the globe.
 

The rising risks of developing peripheral artery disease (PAD) with age, combined with other factors, such as smoking cigarettes, sedentary lifestyle, diabetes, and obesity will drive the market growth. The American College of Cardiology reported in 2023 that PAD affects more than 12 million Americans and 200 million individuals globally. Several market players are developing innovative treatment techniques with massive investments in R&D activities to match the rising demand for more effective and less invasive treatment options for patients with complex PADs.
 

To cite an instance, in June 2023, Endologix received FDA approval for its Detour system to treat long, complex superficial femoropopliteal lesions. Moreover, the growing incidence of hypertension coupled with the high prevalence of cardiovascular diseases have surged the adoption of peripheral interventional devices, propelling the market progress.

The higher cost of therapy and diagnostics associated with peripheral therapies is one of the major restrictions to the peripheral interventions market expansion. According to the American Heart Association, a patient in Canada spends around USD 4,600 per year on treatment and diagnosis of peripheral atrial disease. Additionally, the significant expenses of establishing cath laboratories and the rising attempts to reduce costs may limit the market growth. To cite an instance, a few hospitals in India experienced significant declines in return on investment in cath laboratories due to hampered lab operations. 
 

Covid-19 Impact

The COVID-19 pandemic posed challenges for peripheral intervention practices due to the reduction and suspension of screening programs and services in various nations while bringing significant influence on elective catheterization laboratory activities in hospitals for structural cardiac operations. For instance, the European Society of Cardiology advised postponing of all non-emergency treatments, including peripheral vascular interventions, leading to hampered market growth.  However, the increased focus on telemedicine and remote monitoring influenced the adoption of minimally invasive peripheral intervention techniques, contributing to the industry development.  
 

Peripheral Interventions Market Trends

Rising technological developments for providing enhanced care and improved treatment results coupled with the higher effectiveness of modern gadgets in non-invasive interventional treatments will provide potential growth opportunities for industry growth. The growing intervention by industry players on heavily investing in improving product innovations to further enhance procedure volumes for boosted product demand and expanded client base will also influence the industry growth. For instance, in February 2023, BIOTRONIK received FDA 510(k) clearance and the CE mark for its Oscar® multipurpose peripheral catheter designed for percutaneous transluminal procedures in the peripheral vascular.
 

Peripheral Interventions Market Analysis

Peripheral interventions market from the catheters segment is expected to exhibit 9.3% CAGR from 2023-2032. The growth is owing to the extensive usage of peripheral intravenous catheters (PIVC) for treatment procedures in hospitalized patients. Moreover, the growing emphasis by market participants on discovering and commercializing medical products to revolutionize the treatment of calcified cardiovascular disease is expected to fuel segment trends. For instance, in March 2023, Shockwave Medical, Inc., a leading developer of Intravascular Lithotripsy, received the FDA approval for the commercial launch of the Shockwave L6 Peripheral IVL Catheter.
 

Peripheral interventions market from the peripheral artery disease application segment is foreseen to depict considerable growth at 8.9% CAGR from 2023 to 2032. The growth is attributed to the increasing prevalence of peripheral artery disease (PAD) due to the rapidly aging population and lifestyle factors. Technological advancements in interventional devices and procedures, such as angioplasty and stenting, have led to enhanced treatment outcomes. In July 2023, according to a report by the FDA, stents and paclitaxel-coated balloons have demonstrated to improve blood flow to the legs and lessen the need for further treatments to unblock clogged blood arteries.  Additionally, the rising awareness of the serious complications, including amputation caused by PADs is driving the demand for early diagnosis and intervention, contributing to the segment development.
 

North America peripheral interventions market is poised to amass more than USD 8.1 billion by 2032.  The rising number of geriatric patients vulnerable to several cardiac disorders is expected to surge the demand for several advanced healthcare devices. According to the CDC, in 2021, around 695,000 Americans died from heart diseases.  Moreover, the increasing acceptance of minimally invasive processes in the region is driving the adoption of peripheral interventional solutions. Furthermore, the rising focus of leading manufacturers on strategic efforts to expand their presence in America will augment the market outlook. For instance, in February 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI), a U.S.-based medical device firm for offering new solutions for treating complicated artery conditions.
 

Peripheral Interventions Market Share

The competitive landscape of the peripheral interventions market includes: prominent companies such as

• Biotronik SE & Co. KG
• Teleflex Incorporated
• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical
• W. L. Gore & Associates Inc
• Cardinal Health Inc
• AngioDynamics Inc
•  Medtronic
• B.Braun Melsungen AG
• Terumo Corporation
• Becton Dickinson and Company (C.R. Bard)
   

Peripheral Interventions Infustry News

• In December 2022, Boston Scientific Corporation disclosed plans to acquire majority stake of up to 65% in Acotec, a Chinese medical technology company that provides solutions for various interventional procedures.
   

Peripheral interventions market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Proudct (USD Million)

• Catheters
• Sheath
• Stents
• Bare metal Stents
• Drug-eluting Stents
• Other 
• Guide wires
• Atherectomy devices
• Embolic devices
• Thrombectomy devices
• IVC filters
• Others

By Application (USD Million)

• Peripheral artery disease
• Venous thromboembolism
• Others

By End-use (USD Million)

• Hospitals
• Catheterization laboratories
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey